Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Trillium
Biotech
Pfizer and Trillium: How a $25M investment led to a $2.3B buyout
Pfizer ended up paying a triple-digit premium despite no other companies properly entering the race to buy Trillium.
Nick Paul Taylor
Sep 14, 2021 8:05am
Pfizer deal a spark for M&A, or fuel for an empty pipeline?
Aug 24, 2021 9:32am
Pfizer swallows CD47 biotech Trillium in $2.3B takeover
Aug 23, 2021 8:35am
Trillium unveils CD47 clinical research priorities
Apr 28, 2021 7:00am
Pfizer invests $120M in 4 biotechs through new growth fund
Jan 12, 2021 8:55am
Novartis alums unveil their next act—Chutes & Ladders
Nov 6, 2020 9:30am
